SEC Comment Letter for Odyssey Health, Inc. (ODYY) (CIK 0001626644) (ODYY) — Aug 3, 2022
Odyssey Health, Inc. (ODYY) (CIK 0001626644)
Date: Aug. 3, 2022 · CIK: 0001626644 · Accession: 0000000000-22-008175
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-266422
Letter
United States securities and exchange commission logo August 3, 2022 Joseph Michael Redmond President and Chief Executive Officer Odyssey Health, Inc. 2300 West Sahara Avenue Suite 800 - #4012 Las Vegas, NV 89102 Re:Odyssey Health, Inc. Registration Statement on Form S-1 Filed July 29, 2022 File No. 333-266422 Dear Mr. Redmond: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Joshua D. Brinen
Show Raw Text
United States securities and exchange commission logo
August 3, 2022
Joseph Michael Redmond
President and Chief Executive Officer
Odyssey Health, Inc.
2300 West Sahara Avenue
Suite 800 - #4012
Las Vegas, NV 89102
Re:Odyssey Health, Inc.
Registration Statement on Form S-1
Filed July 29, 2022
File No. 333-266422
Dear Mr. Redmond:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Joshua D. Brinen